Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients
PaperCitations, authors & open-access status
Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 549 citations, 2018 year and closed oa status.
549
Citations
2018
Year
closed
OA Status